(2s)-2-(4-氯苯基)-1-[4-[(5r,7r)-6,7-二氢-7-羟基-5-甲基-5h-环戊基嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙醇
- 英文名称:(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone
- 价格: ¥99/瓶
- 发布日期: 2019-04-01
- 更新日期: 2025-10-15
产品详请
| 产地 |
加拿大
|
| 品牌 |
进口
|
| 货号 |
03-377870
|
| 包装规格 |
5mg,10mg
|
| 纯度 |
98%
|
| CAS编号 |
1001264-89-6
|
| 别名 |
GDC-0068
|
货号:03-377870
中文名称:(2s)-2-(4-氯苯基)-1-[4-[(5r,7r)-6,7-二氢-7-羟基-5-甲基-5h-环戊基嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙醇
英文名称:4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]benzoic Acid
CAS号:1001264-89-6
重量:5mg
重量:10mg
分子式:C24H32ClN5O2
别名:GDC-0068
应用介绍:(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone is a highly selective AKT inhibitor targeting Akt1, Akt2 and Akt3. Studies have shown its use in combination with vemurafenib (V118500), have demonstrated therapeutic value in the treatment of hyperproliferative disorders such as cancer.